Integrin 3D structures: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) New page: ==3D structures of integrin== Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} {{#tree:id=OrganizedByTopic|openlevels=0| *IG CR3 **1ido – hIG I domain ... |
Michal Harel (talk | contribs) No edit summary |
||
(9 intermediate revisions by the same user not shown) | |||
Line 8: | Line 8: | ||
**[[1ido]] – hIG I domain + Mg – human<br /> | **[[1ido]] – hIG I domain + Mg – human<br /> | ||
**[[1jlm]] - hIG I domain + Mn<br /> | **[[1jlm]] - hIG I domain + Mn<br /> | ||
*IG α-1 (CD49a) | *IG α-1 (CD49a) | ||
**[[4a0q]] - hIG I domain (mutant) + Mg<br /> | **[[4a0q]] - hIG I domain (mutant) + Mg<br /> | ||
**[[2l8s]] - hIG transmembrane domain – NMR<BR /> | **[[2l8s]] - hIG transmembrane domain – NMR<BR /> | ||
**[[5hgj]] - hIG VWFA domain<br /> | **[[5hgj]] - hIG VWFA domain<br /> | ||
**[[2m32]] - hIG I domain + collagen peptide<br /> | |||
**[[1ck4]] - rIG I domain – rat<br /> | |||
**[[1mhp]] - rIG I domain (mutant) + antibody + Mn<br /> | **[[1mhp]] - rIG I domain (mutant) + antibody + Mn<br /> | ||
**[[2b2x]] - rIG I domain (mutant) + antibody + Mg<br /> | **[[2b2x]] - rIG I domain (mutant) + antibody + Mg<br /> | ||
*IG α-2 (CD49b) | *IG α-2 (CD49b) | ||
Line 66: | Line 30: | ||
**[[2k1a]] - hIG transmembrane domain – NMR<BR /> | **[[2k1a]] - hIG transmembrane domain – NMR<BR /> | ||
*IG α-1 β-1 (CD49a-CD49b) | *IG α-1 + IG β-1 (CD49a-CD49b) | ||
**[[1qc5]], [[1qcy]] - hIG I domain (mutant) + Mg<br /> | **[[1qc5]], [[1qcy]] - hIG I domain (mutant) + Mg<br /> | ||
**[[1pt6]] - hIG I domain + Mg<br /> | **[[1pt6]] - hIG I domain + Mg<br /> | ||
*IG α-2 (CD49b) β | *IG α-2 (CD49b) + IG β | ||
**[[5hj2]] - hIG I domain<br /> | **[[5hj2]] - hIG I domain<br /> | ||
Line 77: | Line 41: | ||
**[[2k1a]] - hIG transmembrane domain – NMR<br /> | **[[2k1a]] - hIG transmembrane domain – NMR<br /> | ||
*IG α-2b β-3 (CD61) | *IG α-2b + IG β-3 (CD61) | ||
**[[1kup]], [[1kuz]] – hIG proximal domain – NMR<BR /> | **[[1kup]], [[1kuz]] – hIG proximal domain – NMR<BR /> | ||
**[[1m8o]] - hIG cytoplasmic domain – NMR<BR /> | **[[1m8o]] - hIG cytoplasmic domain – NMR<BR /> | ||
**[[4cak]] – hIG – Cryo-EM<br /> | **[[4cak]] – hIG – Cryo-EM<br /> | ||
**[[2k9j]], [[2knc]] - hIG transmembrane domain – NMR<BR /> | **[[2k9j]], [[2knc]], [[7kn0]] - hIG transmembrane domain – NMR<BR /> | ||
**[[1tye]], [[3fcu]], [[3fcs]] – hIG + Mg<br /> | **[[1tye]], [[3fcu]], [[3fcs]] – hIG + Mg<br /> | ||
**[[3fc3]] – hIG (mutant) + Mg<br /> | **[[3fc3]] – hIG (mutant) + Mg<br /> | ||
Line 89: | Line 53: | ||
**[[2vdm]], [[2vdn]], [[3t3m]], [[3t3p]] – hIG headpiece + antibody + antagonist + Mg<br /> | **[[2vdm]], [[2vdn]], [[3t3m]], [[3t3p]] – hIG headpiece + antibody + antagonist + Mg<br /> | ||
**[[2vdo]], [[2vdp]], [[2vdq]], [[2vdr]] – hIG headpiece + antibody + fibrinogen peptide + Mg<br /> | **[[2vdo]], [[2vdp]], [[2vdq]], [[2vdr]] – hIG headpiece + antibody + fibrinogen peptide + Mg<br /> | ||
**[[6v4p]], [[7la4]] – hIG + antibody – Cryo-EM<br /> | |||
**[[7l8p]], [[7tct]], [[7td8]], [[7tho]], [[7tmz]], [[7tpd]], [[7u60]], [[7u9f]], [[7u9v]], [[7ubr]], [[7ucy]], [[7udg]], [[7udh]], [[7ue0]], [[7ufh]], [[7uh8]], [[7uje]], [[7ujk]], [[7uk9]], [[7uko]], [[7ukp]], [[7ukt]] – hIG + antibody + drug<br /> | |||
*IG α-4 | *IG α-4 | ||
Line 94: | Line 60: | ||
**[[4irz]] - hIG + antibody <br /> | **[[4irz]] - hIG + antibody <br /> | ||
*IG α-4 (CD49d) β-7 | *IG α-4 (CD49d) + IG β-7 | ||
**[[3v4p]] - hIG headpiece (mutant) + antibody + Mg<br /> | **[[3v4p]] - hIG headpiece (mutant) + antibody + Mg<br /> | ||
**[[3v4v]] - hIG headpiece (mutant) + antibody + inhibitor + Mg<br /> | **[[3v4v]] - hIG headpiece (mutant) + antibody + inhibitor + Mg<br /> | ||
*IG α-5 (CD49e) β-1 (CD29) | *IG α-5 (CD49e) + IG β-1 (CD29) | ||
**[[7nxd]] – hIG + Mg – Cryo-EM<br /> | |||
**[[7nwl]] – hIG + fibronectin + laminin – Cryo-EM<br /> | |||
**[[4wjk]] - hIG headpiece (mutant) + Mg<br /> | **[[4wjk]] - hIG headpiece (mutant) + Mg<br /> | ||
**[[4wk0]], [[4wk2]], [[4wk4]] - hIG headpiece (mutant) + peptide + Mg<br /> | **[[4wk0]], [[4wk2]], [[4wk4]] - hIG headpiece (mutant) + peptide + Mg<br /> | ||
Line 106: | Line 74: | ||
**[[3vi4]] - hIG headpiece + antibody + peptide + Mg<br /> | **[[3vi4]] - hIG headpiece + antibody + peptide + Mg<br /> | ||
*IG α-5 (CD49e) β-3 (CD61) ectodomain | *IG α-5 (CD49e) + IG β-3 (CD61) ectodomain | ||
**[[3ije]], [[1m1x]], [[4g1e]], [[4g1m]], [[1u8c]] – hIG + cation<br /> | **[[3ije]], [[1m1x]], [[4g1e]], [[4g1m]], [[1u8c]] – hIG + cation<br /> | ||
Line 114: | Line 82: | ||
**[[1l5g]] - hIG + tripeptide + Mn<br /> | **[[1l5g]] - hIG + tripeptide + Mn<br /> | ||
*IG α-5 β-6 | *IG α-5 + IG β-6 | ||
**[[4um8]] – hIG headpiece (mutant) + Ni<br /> | **[[4um8]] – hIG headpiece (mutant) + Ni<br /> | ||
Line 121: | Line 89: | ||
**[[5neu]], [[5net]], [[5ner]], [[5nem]] – hIG headpiece + foot-and-mouth virus – Cryo EM<br /> | **[[5neu]], [[5net]], [[5ner]], [[5nem]] – hIG headpiece + foot-and-mouth virus – Cryo EM<br /> | ||
**[[5ffo]] – hIG headpiece + TGF-beta-1<br /> | **[[5ffo]] – hIG headpiece + TGF-beta-1<br /> | ||
*IG α-6 + IG β-1 | |||
**[[7ceb]], [[7cec]] – hIG headpiece + laminin + Mg<br /> | |||
*IG α-L | *IG α-L | ||
**[[4ixd]] – hIG | **[[1lfa]] - hIG I domain + Mn <br /> | ||
**[[1zon]], [[4ixd]], [[7kc3]] - hIG I domain 153-334 <br /> | |||
**[[1mqa]] - hIG I domain (mutant) <br /> | |||
**[[1zoo]], [[1zop]], [[3f74]] - hIG I domain + Mg <br /> | |||
**[[1mq9]] - hIG I domain (mutant) + Mn <br /> | |||
**[[1mjn]] - hIG I domain (mutant) + Mg <br /> | |||
**[[2k8o]] – hIG cytoplasmic domain (mutant) – NMR <br /> | |||
**[[5e6s]], [[5e6r]] – hIG AI, headpiece,pocket domains + Mg<br /> | **[[5e6s]], [[5e6r]] – hIG AI, headpiece,pocket domains + Mg<br /> | ||
**[[2m3e]] – hIG transmembrane domain - NMR<br /> | **[[2m3e]] – hIG transmembrane domain - NMR<br /> | ||
*IG α-L β-2 | *IG α-L complexes | ||
**[[1cqp]] - hIG I domain + lovastatin + Mg <br /> | |||
**[[1mq8]], [[3bn3]], [[3tcx]] - hIG I domain (mutant) + intracellular adhesion molecule + Mg <br /> | |||
**[[1t0p]] - hIG I domain + intracellular adhesion molecule-3 + Mg<br /> | |||
**[[1rd4]], [[2ica]], [[3bqm]], [[3bqn]], [[3e2m]] - hIG I domain + inhibitor<br /> | |||
**[[2o7n]], [[3m6f]] - hIG I domain + antagonist<br /> | |||
**[[1xdd]], [[1xdg]], [[1xuo]], [[7kc5]] - hIG I domain + inhibitor + Mg<br /> | |||
**[[7kc6]] - hIG I domain + drug + Mg<br /> | |||
**[[3f78]] - hIG I domain + anesthetic + Mg<br /> | |||
**[[3eoa]], [[3eob]] - hIG I domain + antibody<br /> | |||
**[[3hi6]] - hIG I domain (mutant) + antibody + Mn<br /> | |||
*IG α-L + IG β-2 | |||
**[[5e6u]] – hIG headpiece (mutant) + Ni<br /> | **[[5e6u]] – hIG headpiece (mutant) + Ni<br /> | ||
Line 134: | Line 124: | ||
*IG α-M | *IG α-M | ||
**[[1idn]], [[1na5]] - hIG<br /> | |||
**[[1mf7]] - hIG (mutant) <br /> | |||
**[[1bho]] - hIG + Mg<br /> | |||
**[[1bhq]] - hIG + Cd<br /> | |||
**[[1m1u]] - hIG (mutant) + Ca<br /> | |||
**[[1n9z]] - hIG (mutant) + Mg<br /> | |||
**[[3q3g]], [[3qa3]] – hIG + antibody<br /> | **[[3q3g]], [[3qa3]] – hIG + antibody<br /> | ||
**[[4m76]] – hIG + complement C3<br /> | **[[4m76]] – hIG + complement C3<br /> | ||
**[[2lke]], [[2lkj]] – hIG cytoplasmic domain – NMR< | **[[2lke]], [[2lkj]] – hIG cytoplasmic domain – NMR<br /> | ||
**[[4xw2]] – hIG + simvastatin<br /> | **[[4xw2]] – hIG + simvastatin<br /> | ||
**[[6rhv]], [[6rhw]] – hIG + cytolysin<br /> | |||
*IG α-M + IG β-2 | |||
**[[7usm]] – hIG ectodomain – Cryo EM<br /> | |||
**[[7usl]] – hIG ectodomain + adenylate cyclase toxin + antibody – Cryo EM<br /> | |||
**[[7p2d]] – hIG ectodomain + nanobody <br /> | |||
*IG α-V + IG β-3 | |||
**[[6mk0]] – hIG + antagonist<br /> | |||
**[[6msl]] – hIG + cysteine knot protein<br /> | |||
**[[6msu]] – hIG + EETI-II<br /> | |||
**[[6naj]] – hIG + fibronectin<br /> | |||
*IG α-V β-8 | *IG α-V + IG β-8 | ||
**[[6djp]] – hIG + antibody – Cryo EM<br /> | **[[6djp]], [[6ujb]], [[6ujc]] – hIG + antibody – Cryo EM<br /> | ||
**[[6om1]] – hIG (mutant)<br /> | |||
**[[6om2]] – hIG (mutant) + Protgf-b1 RGD peptide<br /> | |||
**[[6uja]] – hIG + Protgf-b1 RGD – Cryo EM<br /> | |||
**[[7y1t]] – hIG + TGF-b1 – Cryo EM<br /> | |||
*IG α-X | *IG α-X | ||
**[[2luv]] – hIG cytoplasmic domain – NMR<BR /> | **[[2luv]] – hIG cytoplasmic domain – NMR<BR /> | ||
**[[1n3y]] – hIG domain I (mutant)<br /> | |||
*IG α-X β-2 (CD18) | *IG α-X + IG β-2 (CD18) | ||
**[[3k6s]], [[3k71]], [[3k72]], [[5es4]] – hIG + Mg<br /> | **[[3k6s]], [[3k71]], [[3k72]], [[5es4]] – hIG + Mg<br /> | ||
Line 169: | Line 184: | ||
**[[2l1c]] – hIG cytoplasmic tail + SHC<br /> | **[[2l1c]] – hIG cytoplasmic tail + SHC<br /> | ||
**[[2mtp]] – hIG cytoplasmic tail (mutant) + hIG α-2 β peptide+ filamin rod domain<br /> | **[[2mtp]] – hIG cytoplasmic tail (mutant) + hIG α-2 β peptide+ filamin rod domain<br /> | ||
**[[6bxb]], [[6bxf]] – hIG/hIG α-L <br /> | |||
*IG β-4 (CD104; Gp150) | *IG β-4 (CD104; Gp150) |
Latest revision as of 11:32, 31 May 2023
3D structures of integrin3D structures of integrin
Updated on 31-May-2023
- 4irz - hIG + antibody
- 4irz - hIG + antibody
- IG α-4 (CD49d) + IG β-7
- IG α-5 (CD49e) + IG β-1 (CD29)
- IG α-5 (CD49e) + IG β-3 (CD61) ectodomain
- IG α-5 + IG β-6
- IG α-6 + IG β-1
- IG α-L
- 1lfa - hIG I domain + Mn
- 1zon, 4ixd, 7kc3 - hIG I domain 153-334
- 1mqa - hIG I domain (mutant)
- 1zoo, 1zop, 3f74 - hIG I domain + Mg
- 1mq9 - hIG I domain (mutant) + Mn
- 1mjn - hIG I domain (mutant) + Mg
- 2k8o – hIG cytoplasmic domain (mutant) – NMR
- 5e6s, 5e6r – hIG AI, headpiece,pocket domains + Mg
- 2m3e – hIG transmembrane domain - NMR
- 1lfa - hIG I domain + Mn
- IG α-L complexes
- 1cqp - hIG I domain + lovastatin + Mg
- 1mq8, 3bn3, 3tcx - hIG I domain (mutant) + intracellular adhesion molecule + Mg
- 1t0p - hIG I domain + intracellular adhesion molecule-3 + Mg
- 1rd4, 2ica, 3bqm, 3bqn, 3e2m - hIG I domain + inhibitor
- 2o7n, 3m6f - hIG I domain + antagonist
- 1xdd, 1xdg, 1xuo, 7kc5 - hIG I domain + inhibitor + Mg
- 7kc6 - hIG I domain + drug + Mg
- 3f78 - hIG I domain + anesthetic + Mg
- 3eoa, 3eob - hIG I domain + antibody
- 3hi6 - hIG I domain (mutant) + antibody + Mn
- 1cqp - hIG I domain + lovastatin + Mg
- IG α-L + IG β-2
- 5e6u – hIG headpiece (mutant) + Ni
- 5e6u – hIG headpiece (mutant) + Ni
- IG α-M
- IG α-M + IG β-2
- IG α-V + IG β-3
- IG α-V + IG β-8
- IG α-X
- IG α-X + IG β-2 (CD18)
- IG β-1D
- 3g9w – hIG cytoplasmic tail + talin 2 F2-F3 domain
- 3g9w – hIG cytoplasmic tail + talin 2 F2-F3 domain
- IG β-2 (CD18)
- IG β-3 (CD61)
- IG β-4 (CD104; Gp150)
- 2f7q, 3f7r, 1qg3, 3f7q, 4wtw, 4wtx - hIG fibronectin type III domain
- 2yrz – hIG fibronectin type III domain – NMR
- 3f7p, 4q58 - hIG fibronectin type III domain + plectin-1
- 6gvl - hIG fibronectin type III domain + dystonin
- 6gvk - hIG fibronectin type III domain (mutant) + dystonin
- 3fq4, 3fso, 3h6a – hIG Calx-β domain
- 6hyf - rIG fibronectin type III domain
- 2f7q, 3f7r, 1qg3, 3f7q, 4wtw, 4wtx - hIG fibronectin type III domain
- IG β-7